1. Raghu G et al. Am J Respir Crit Care Med 2018;198:e44–e68.
2. Kreuter M et al. Respir Res 2019;20(1):59.
3. Fan Y et al. Chest 2020; doi: 10.1016/j.chest.2019.12.041.
4. Richeldi L et al. N Engl J Med 2011;365:1079–87.
5. Richeldi L et al. N Engl J Med 2014;370:2071–82.

The TOMORROW and INPULSIS trials were funded by Boehringer Ingelheim. Editorial and formatting assistance, supported financially by Boehringer Ingelheim, was provided by Julie Fleming and Wendy Morris of FleishmanHillard Fishburn, London, UK during preparation of this poster. The authors were fully responsible for all content and editorial decisions, were involved at all stages of poster development and have approved the final version. Boehringer Ingelheim was given the opportunity to review the poster for medical and scientific accuracy as well as intellectual property considerations. The authors received no direct compensation related to the development of this poster. Steven D Nathan serves as a consultant for and is on the speaker bureaus for Boehringer Ingelheim and Roche-Genentech. Athol U Wells reports personal fees from Blade Therapeutics, Boehringer Ingelheim, and Roche.